In re: Fosamax (Alendronate Sodium) Products Liabi
| PHYLLIS MOLNAR, and all other plaintiffs listed in Exhibit A to notice of appeal |
| MERCK & CO INC, MERCK SHARP & DOHME CORP, SUN PHARMA GLOBAL, NOVARTIS PHARMACEUTICALS CORP, APOTEX INC, COBALT LABORATORIES INC, TEVA PHARMACEUTICAL INDUSTRIES LTD, MCKESSON CORP, TEVA PHARMACEUTICALS USA INC, COBALT PHARMACEUTICALS INC, NORTHSTAR RX LLC, GLAXOSMITHKLINE LLC, HOFFMAN LA ROCHE INC, ROCHE HOLDINGS, ROCHE LABORATORIES INC, ROCHE THERAPEUTICS INC, SMITHKLINE BEECHAM CORP, GENENTECH INC, WARNER CHILCOTT PHARMACEUTICALS, PROCTOR & GAMBLE PHARMACEUTICALS INC, PHARMACEUTICALS INC, WARNER CHILCOTT US LLC, SANOFI AVENTIS US LLC, SANOFI AVENTIS U.S. INC, SANOFI AVENTIS US SERVICES INC, GENENTECH USA INC, MERCK SHARP & DOHME, DR REDDYS LABORATORIES INC and WATSON LABORATORIES INC |
| 22-3412 |
| December 22, 2022 |
| U.S. Court of Appeals, Third Circuit |
| Personal Injury-Product Liability |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 7, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 18 ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellant Phyllis Molnar advising this court that transcripts are already on file in the District Court. [22-3412] (DCF) [Entered: 02/07/2023 04:58 PM] |
| Filing 17 ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellant Phyllis Molnar. [22-3412] (DCF) [Entered: 02/07/2023 04:58 PM] |
| Filing 16 ECF FILER: Concise Summary of the Case filed by Appellant Phyllis Molnar. [22-3412] (DCF) [Entered: 02/07/2023 04:56 PM] |
| Filing 15 ECF FILER: ENTRY OF APPEARANCE from James A. Ruck on behalf of Appellant(s) Sybil Edwards. Also designated by appellants to file a consolidated appellants' brief. [22-3412] (JR) [Entered: 01/30/2023 02:53 PM] |
| Filing 14 ECF FILER: ENTRY OF APPEARANCE from Ariela M. Migdal on behalf of Appellant(s) Sybil Edwards. Also designated by appellants to file a consolidated appellants' brief. [22-3412] (AM) [Entered: 01/30/2023 02:51 PM] |
| Filing 13 ECF FILER: ENTRY OF APPEARANCE from David C. Frederick on behalf of Appellant(s) Sybil Edwards. Also designated by appellants to file a consolidated appellants' brief and argue on behalf of all appellants.. [22-3412] (DCF) [Entered: 01/30/2023 02:49 PM] |
| Filing 12 SECOND FOLLOW UP LETTER to All Counsel for Appellees' requesting the following document(s): Appearance Form and Disclosure Statement on or before 02/08/2023. If the forms are not received by the deadline, it will be presumed that you do not wish to participate in the appeal and you will no longer receive notice of filings in the appeal. (It is noted that this Letter does not apply to Counsel for Appellee Merck Sharp & Dohme Corp who have filed the requested forms.) (CJG) [Entered: 01/25/2023 04:26 PM] |
| Filing 11 SECOND FOLLOW UP LETTER to David R. Buchanan, Esq., James E. Cecchi, Esq. and Christopher A. Seeger, Esq. for Phyllis Molnar requesting the following document(s): Appearance Form, Information Statement, Concise Summary and Transcript Purchase Order on or before 02/08/2023. If the forms are not filed by the deadline the appeal will be dismissed. (CJG) [Entered: 01/25/2023 04:20 PM] |
| Filing 10 ECF FILER: ENTRY OF APPEARANCE from Karen A. Confoy on behalf of Appellant(s) Merck Sharp & Dohme Corporation. [22-3412] (KAC) [Entered: 01/25/2023 02:37 PM] |
| Filing 9 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Merck Sharp & Dohme Corp. [22-3412] (JMR) [Entered: 01/12/2023 12:57 PM] |
| Filing 8 FOLLOW UP LETTER to All Counsel for Appellees' requesting the following document(s): Appearance Form and Disclosure Statement on or before 01/23/2023. (CJG) [Entered: 01/09/2023 11:08 AM] |
| Filing 7 FOLLOW UP LETTER to David R. Buchanan, Esq., James E. Cecchi, Esq. and Christopher A. Seeger, Esq. for Appellant Phyllis Molnar requesting the following document(s): Appearance Form, Information Statement, Concise Summary and Transcript Purchase Order on or before 01/23/2023. (CJG) [Entered: 01/09/2023 11:03 AM] |
| Filing 6 ECF FILER: ENTRY OF APPEARANCE from John R. Boule III on behalf of Appellee(s) Merck Sharp & Dohme Corp.. [22-3412] (JRB) [Entered: 01/03/2023 01:32 PM] |
| Filing 5 ECF FILER: ENTRY OF APPEARANCE from Jeffrey R. Johnson on behalf of Appellee(s) Merck Sharp & Dohme Corp.. [22-3412] (JRJ) [Entered: 01/03/2023 01:30 PM] |
| Filing 4 ECF FILER: ENTRY OF APPEARANCE from Jacob M. Roth on behalf of Appellee(s) Merck Sharp & Dohme Corp.. [22-3412] (JMR) [Entered: 01/03/2023 01:28 PM] |
| Filing 3 RECORD available on District Court CM/ECF. (CJG) [Entered: 12/22/2022 11:13 AM] |
Filing 2
ORDER (Clerk) This multi-district litigation involves over a thousand plaintiffs who all have individual civil action numbers assigned to their cases. The plaintiffs listed in Exhibit A to the notice of appeal have filed a joint appeal. To facilitate docket management and electronic filing in this case, the Clerk's Office will only enter the lead plaintiff, Phyllis Molnar, the lead civil action number, 3-08-cv-00008, and co-liaison counsel on the docket. All filings on behalf of Appellants shall apply to all persons listed in Exhibit A of the notice of appeal and their respective civil action numbers absent notice of withdrawal by a specific party. A copy of Exhibit A of the notice of appeal is appended to this order. If any Appellant is represented by separate counsel, said counsel shall call the Clerk's Office prior to entering an appearance. (CJG) [Entered: 12/22/2022 11:13 AM]
|
| Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellant Phyllis Molnar in District Court No. 3-08-cv-00008. (CJG) [Entered: 12/22/2022 11:10 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
